Rashida A. Khakoo, MD, MACP

Vice Chair Scholarship & Faculty Development
Professor & Section Chief of Infectious Diseases

Organization:

West Virginia University School of Medicine

Department:

Medicine

Classification:

Faculty

• MD, Makerere University

1. Cummings K, Smith T, Shogren E, Khakoo R, Nanda S, Bunner L, Smithmyer A, Soccorsi D, Kashon M, Friedman L. Prospective Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Assay for the Detection of Latent Tuberculosis Infection among Healthcare Workers in a Low-Incidence Setting. Infection Control and Hospital Epidemiology, November 2009; Vol. 30, No.11.

2. Ahmad S, Khakoo R. Left knee prosthesis-related Mycobacterium goodii infection. International Journal of Infectious Diseases, December 2010: Vol. 14, No. 12.

3. Lindsley W, Beezhold D, Blachere F, Clark K, Vishnu A, Davis K, Fisher M, Noti J, Khakoo R, Thewlis R. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS ONE, November 2010; 30:5(11) e15100

4. Lindsley WG , Blachere FM, Davis KA, Pearce TA, Fisher MA, Khakoo R, Davis SM, Rogers ME, Thewlis RE, Posada JA, Redrow JB , Celilk IB, Chen BT, Beezhold DH.  Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clinical Infectious Dis.  2010 Mar 1; 50 (5): 693-8.

5. Khan FA, Khakoo RA. Non-tuberculous mycobacterial cutaneous infection:  an updated review. Cutis 2011, Oct; 88; 194-200.

6. Lindsley WG, Pearce TA, Hudnall JB, Davis KA, Davis SM, Fisher MA, Khakoo R, Palmer JE, Clark KE, Coffey CC, Blachere FM, Beezhold DH.  Quantity and size Distribution of Cough-Generated Aerosol Particles Produced by Influenza Patients During and After Illness.   J Occupational and Environmental Hygiene 2012 (7) 443-9.

7. Roidad, N, Khakoo R.   Vesico-pustular blastomycosis.  Int J Infect Dis. 16 (10):e763-4 (2012), PMID 22704726.

8. Roidad, Nasira, MD, Rashida Khakoo, MD, MACP,   Knowledge and Attitudes of Visitors to Patients in Contact Isolation.  American Journal of Infection Control 2014: Feb; 42, 198-9. PMID: 24485377

9. Khakoo, Rashida, MD, Sweet, Michael, M.D., LaSala, P. Rocco, M.D., Smithmyer, Ann, M.D., Briggs, Frank, M.D., McCullers, Jon M.D.  Comparison of Immune Response to the Influenza Vaccine in Obese and Non-obese Healthcare Workers. Infection Control and Hospital Epidemiology Vol. 36, Issue 03, March 2015 pp. 249-253.

10. Waqar, Sana, MD, Nigh Kathy, RN, Sisler, Lori MSN, RN, BC, Fanning, Mary DNP, RN, NE-BC, Tancin, Steven, Brozik, Erin RN, MSN, Jones, Rebekah, PharD, Briggs, Frank PharmD, MPH, Keller, Lisa BCPS, PharmD, LaSala, P. Rocco, MD, Krautz, Sam, Khakoo, Rashida MD, MACP.  Multidisciplinary performance improvement team for reducing health care associated Clostridium difficile infection.  American Journal of Infection Control; November (2015) 1-3.  PMID: 26541068

11. Lastinger, A., Gomez, K., Manegold, E., Khakoo, R.  Use of a patient empowerment tool for hand hygiene. Am. J. Infect Control. 2017 August 1;45(8): 824-829  PMID: 28768590

1. Invited speaker, “Enhancing our Mission of Education,” for Grand Rounds in the honor of an eminent educator, Dr. Pedigo, at the University of Louisville in Louisville, Kentucky, on November 6, 2008.

2. Quality Award 2010 from Ruby Memorial Hospital for leading H₁N₁ Influenza Team.

3. Paper nominated for the 2010 Charles C. Shephard Science Award by the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry for “Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic.”

4. Received Bravo Award from WVU Health Care for Performance  Improvement Reducing Central Line Blood Stream Infection.  May 2012.

5. Nominated for Dean’s Excellence Award for Dedication to the Profession of Medicine. 2012

6. Nominated for Outstanding Faculty Award Department of Medicine 2013

7. Nominated for distinguished Teaching Award School of Medicine 2013

8. Chancellor’s Award for Mentoring 2014

9. Bravo Award for Leading Ebola Team, June 2015

10. Dedicated Service Award - Mid Atlantic AIDS Education and Training Center, April 5, 2016.

11. Clinical Teacher Award – Infectious Diseases Society of American, Oct. 2016

PROFESSIONAL ASSOCIATIONS

Member, American College of Physicians 1975-1979

Fellow, American College of Physicians 1979-2005

Master, American College of Physicians 2006-present

Member, American Federation for Clinical Research 1975

Member, Infectious Diseases Society of America 1979-1984

Fellow, Infectious Diseases Society of America 1984-present

Member, Society for Health Care Epidemiologists of America 1982-2004

Fellow, Society for Health Care Epidemiologists of America 2004-present

Rashida Khakoo, MD, MACP, is currently Professor of Medicine, Chief, Section of Infectious Diseases, Assistant Vice President Health Sciences Center (Faculty Development) at West Virginia University (WVU). She obtained her medical degree from Makerere University Medical School in Uganda, East Africa and completed her Internal Medicine residency at George Washington University, Washington DC, and fellowship in Infectious Diseases at University of Florida.

She has received many awards for outstanding teaching including WVU Foundation Award. She received the Laureate Award from WV Chapter of American College of Physicians (ACP) in 1994 and was awarded Mastership from ACP in 2006. During 2007, she received the Martin Luther King Award for “Sharing of Self” and the Governor’s Civil Rights Award. She was the recipient of the 2014 Health Science Center Chancellor’s Award for Outstanding Mentorship.  She received the Clinical Teacher Award from the Infectious Diseases Society of America in 2016.

She has had many diverse leadership roles at WVU and beyond. She was instrumental in developing interdisciplinary Teaching Scholars Program for faculty across all schools of health sciences. Her research interests are in health care epidemiology and influenza. She served as Governor of the West Virginia Chapter of ACP from 1999-2003. She has provided leadership for many collaborative programs across West Virginia for HIV/AIDS education for health care professionals. She also served as Chairman, National Committee of Aga Khan Foundation (AKF) USA from 1997-2006. AKF is a non-denominational international development agency whose mission is “to develop and promote creative solutions to problems that impede social development.”

1. Institutional grant 2-210-1615(109) "Effect of alcohol on alveolar macrophage function," $2,500  (1977-1978). Principal Investigator.

2. Institutional grant 2-210-1615(153) Extension of above grant,  "Effect of alcohol in rabbits on the in vitro function of alveolar macrophages obtained by lung lavage technique," $2,500 (1978-1979).  Principal Investigator.

3. Grant from Schering Corporation.  "Comparative efficacy (by calculation of 50% protective dose) of gentamicin, netilmicin, cephalothin, cefamandole, and cefoxitin against gram negative bacterial infections in mice," $12,000 (1978-1979). Principal Investigator.

4. Institutional Grant 6600.550 (013), "Effect of antimicrobials (Singly or in combination) against ampicillin sensitive or resistant E. coli infection in neutropenic mice,” $1,800 (1979-1980).  Principal Investigator.

5. Newport Pharmaceuticals.  "Effect of aerosolized versus oral inosiplex on pulmonary alveolar macrophage function and response to influenza vaccine in rabbits," $27,500 (1981-1982).  Principal     Investigator.

6. Newport Pharmaceuticals.  "Effect of inosiplex on infectious mononucleosis:  A double blind placebo controlled study," $50,000 (1983-1985).  Principal Investigator.

7. Ribovich J, Khakoo R, McKenzie R, and Chiodo V.  Effect of aminoglycosides, ticarcillin and imipenem alone and in combination against Pseudomonas aeruginosa infection in neutropenic Biomedical Research Grant.  "Effect of cefotaxime, moxalactam, cefoperazone, tobramycin, gentamicin, ticarcillin, piperacillin mouse model," $2,000 .550 (089).  Principal Investigator.  

8. Grant from Glaxo.  Comparative trial of Cefaclor versus Cefuroxime for the treatment of UTI. Collaborator, $40,000 (1986).

9. Parke-Davis $25,000.  "Development of Oral Influenza Vaccine."  Principal Investigator, Dr. Waldman.

10. Sterling-Winthrop Research Laboratories 3/88-11/88.  $9,000. "Multiple Dose Comparative Trial of Amifloxacin Versus Trimethoprim-Sulfamethoxazole in the Treatment of Females with Uncomplicated Urinary Tract Infection."  Principal Investigator.  Co-Investigators:  Melanie Fisher, M.D., Edwin Morgan, M.D.

11. Pfizer Central Research, 1988/89; $62,184.  "A Multicenter Open Comparative Study of Sultamicillin Versus Augmentin to Evaluate Toleration, Safety, and Efficacy in the Treatment of Acute Bacterial Lower Respiratory Tract Infection."  Principal Investigator.  Co-Investigators: Melanie Fisher, M.D., Henry Abrons, M.D., Roxanne Powers, M.D.

12. American Cyanamid, Inc. (Lederle Labs)  1/89    $46,680  "A Multicenter, Double-Blind, Comparative Safety Tolerance and Efficacy Study of Parenteral Piperacillin/Tazobactam (CL 298, 741) Versus Ceftazidime for the Treatment of Hospitalized Patients with Complicated Urinary Tract Infection." Principal Investigator.  Co-Investigator:  Melanie A. Fisher, M.D., Raymond Smego, M.D.

13. Hoechst-Roussel.  2/89  $47,355.   "A multicenter observer-blind, randomized study of the safety, efficacy,   and tolerance of cefpirome versus ceftriaxone in the treatment of patients with community acquired pneumonia.  Principal Investigator.  Co-Investigators:  Melanie A. Fisher, M.D., Raymond Smego, M.D.

14. RO 23-6240 (Fleroxacin) In Uncomplicated Urinary Tract Infections In Women.  A randomized, double-blind, prospective study versus Ciprofloxacin.  Principal Investigator:R. Brooks Gainer, II, M.D.  Co-Investigator:  Rashida A. Khakoo, M.D.  Hoffman-LaRoche, Inc.  $120,000.

15. Open-label, comparative, safety, tolerance, and efficacy study of Parenteral Piperacillin/Tazobactam plus Tobramycin versus Ceftazidime plus Tobramycin for the treatment of patients with hospital-acquired lower respiratory tract infection.  Principal Investigator:  Rashida A. Khakoo, M.D.   $49,749.  Co-investigators:  Melanie A. Fisher, M.D., Raymond Smego, M.D.

16. A multicenter, observer-blind, randomized study of the safety, efficacy, and tolerance of Cefpirome vs Ceftriaxone in the treatment of patients with skin and soft tissue infections.  Principal Investigator:  R. Brooks Gainer, II,   M.D. Co-Investigator:  Rashida A. Khakoo, M.D.

17. Effect of chlorine dioxide on various microorganisms likely to be contained in infectious waste.  Winfield Corporation.  Principal Investigator.  $157,574.70.  1991-1993.

18. In vitro susceptibility using MIC/MBC of 100 consecutive isolates causing nosocomial infections in intensive care units to third generation cephalosporus, imipenem and aztreonam.  Merck, Sharp & Dohme.  $16,000. 1993.

19. Colonization rates of ventilator circuits and patients' respiratory tracts following 5 or 7 day circuit changes as compared to the currently recommended duration of 48 hours.  Ruby Memorial Hospital. Patient Care Enhancing Program - Principal Investigator.  $21,294. 1993-1994.

20. Immunizations in Rural West Virginia.  Strategic Planning Initiative.  Robert C. Byrd Health Sciences Center.  PI: Melanie Fisher, M.D., Co-investigators: Rashida Khakoo, M.D., Renee Moore, M.D., Norman Ferrari, M.D.  ($15,000). 

21. Enhancement Capacity for Public Health Surveillance and Response to Infectious Diseases.  West Virginia Department of Health and Human Services and the Centers for Disease Control and Prevention. Principal Investigator-Melanie Fisher.  Co-Investigator-Rashida Khakoo, M.D. $31,564 95/96, $31,957 96/97, $37,849 97/98, $34,038 98/99.

22. Cooperative Agreement Program to “Refine a National Surveillance System for Hospital Health Care Workers”.  Centers for Disease Control.  PI-Melanie Fisher, M.D., Co-PI: Rashida Khakoo, M.D. $60,571 97/98, $30,285 98/99.

23. Using the National Surveillance System for Hospital Health Care Workers to Reduce Percutaneous Injuries Among Health Care Workers.  Granting agency:  Centers for Disease Control and Prevention.  PI: Melanie Fisher, M.D., M.Sc., Co-PI: Rashida Khakoo, M.D. ($58,114).

24. “Planning for Comprehensive HIV primary Care Services in Rural and Medically Underserved West Virginia”.  U.S. Department of Health and Human Services, Health Resources and Services Administration (2002) Grant application No. 1 P06 HA 000637 01.  PI: Arif Sarwari, Co-PI: Rashida Khakoo ($50,000).

25. “Building Capacity in Rural and Medically Underserved West Virginia”.  U.S. Department of Health and Human Services, Health Resources and Services Administration (2002) Grant application No. 1 P06 HA 000586 01.  PI: Arif Sarwari, Co-PI: Rashida Khakoo ($150,000).

26.* Pennsylvania MidAtlantic AIDS Regional Education and Training Center Grant from HRSA.Co-Principal Investigator:  Rashida Khakoo.  1989/90 --$31,000; 1990/91 -- $64,000; 1991/92--$45,000; 1992/93--$83,727; 1993/94--$82,136; 1994/95-- $80,738; 1995/96—$94,289; 1996/97 $77,000; 1997/98 -- $100,000; 1998/99 --  $100,000; 1999/00 -- $129,419; 2000/01 -- 189,814; 2001/02 -- $252,000; 2002/03 -- $320,067; 2003/04 -- $307,567; 2004/05 -- $313,517; 2005/06 --$301,000; 2006/07 -- $301,444; 2007/08 -- $306,444; 2008/09 -- $304,444; 2009/10 -- $292,644; 2010/11 -- $288,433: 2011/12 --$281,732, 2012/13 - $278,280, 2013/14 - $255,808; 2014/15 - $293,708; 2015/16 - $220,000 (9 month award only); 2016/17 - $241,552.

27.  West Virginia Prepares:  Continuing Education Partnership grant from HRSA, Co-I, R. Khakoo.  PI was Dr. Floyd K. Russell, EdD. ($815,573).

28.*      Developing Center of Excellence for Outpatient HIV Care at WVU Early Intervention Services grant from HRSA Part C.  PI: Arif Sarwari, Collaborator: Rashida Khakoo. Grant Award H76HA01719

2003-2007-- $1,093,055; 4/1/07–3/31/08 -- $292,500; 4/1/08 – 3/31/09 -- $393,714; 4/1/2009 – 3/31/2010 -- $393,714; 4/1/010 – 3/31/2011--$393,714: 4/1/2011 – 3.31.2012 --$393,714, 3/31/2012-4/1/2013 -- $431,714 , 4/1/13-3/31/14--$412,028, 4/1/14-3/31/15--$412,028, 4/1/15-3/31/16--$412,028, 4/1/16-3/31/17--$412,028, 4/1/17-3/31/18--$412,028

29.* Developing Center of Excellence for Outpatient HIV Care for Women and Youth.  PI:  Arif Sarwari, Collaborator: Rashida Khakoo.  Part D – Grant Award H12HA24866 8/1/2012-7/31/2013 -- $219,572, 8/1/2013-7/31/2014--$208,218, 8/1/2014-7/31/2015--$208,218, 8/1/2015-7/31/2016--$208,218, 8/1/2016-7/31/2017--$208,218, 8/1/2017-7/31/2018--$227,958

30. Experimental and Theoretical Study of Early Detection and Isolation of Influenza.  Centers for Disease Control/NIOSH, PI: Ismail Celik, Co-PI : Rashida Khakoo.  $692,241). 8/06 – 07/09.

31.* AETC Appalachian Telehealth Project.  PI: D.L. Frank, PhD, University of Pittsburgh, Co-PI: Rashida Khakoo.  Grant from HRSA   2012-2013 $51,000, 2013-2014 $50,000

*current

Medical Specialties

• Infectious Diseases

Board Certifications

• Infectious Diseases, American Board of Internal Medicine
• Internal Medicine, American Board of Internal Medicine

Special Training

• Residency, Residency
  George Washington University
• Fellowship, Fellowship
  University of Florida